Results 301 to 310 of about 2,123,606 (402)

A case of surgical treatment for recurrence of right ventricular metastasis due to renal cell carcinoma after molecular targeted therapy. [PDF]

Surg Case Rep
Sasaki K, Nishioka N, Yamamoto M, Kato K, Matsumoto R, Masuda T, Maruyama R, Kurimoto Y, Yamada A, Naraoka S.   +9 more
europepmc   +1 more source

Cancer Metastases from Lung Adenocarcinoma Disappeared After Molecular Targeted Therapy: A Successfully Clinical Treatment Experience. [PDF]

Pharmgenomics Pers Med, 2022
Li MJ, Wei J, Ai GP, Liu Y, Zhu J.
europepmc   +1 more source

Surgery of Residual Disease Following Molecular-targeted Therapy With Imatinib Mesylate in Advanced/Metastatic GIST

, 2007
Alessandro Gronchi, Marco Fiore, Francesca Miselli, Maria Stefania Lagonigro, Paola Coco, A. Messina, Silvana Pilotti, Paolo G. Casali   +7 more
openalex   +2 more sources

Chemoresistome mapping in individual breast cancer patients unravels diversity in dynamic transcriptional adaptation

Molecular Oncology, EarlyView.
This study used longitudinal transcriptomics and gene‐pattern classification to uncover patient‐specific mechanisms of chemotherapy resistance in breast cancer. Findings reveal preexisting drug‐tolerant states in primary tumors and diverse gene rewiring patterns across patients, converging on a few dysregulated functional modules. Despite receiving the
Maya Dadiani, Gilgi Friedlander, Gili Perry, Nora Balint‐Lahat, Shlomit Gilad, Dana Morzaev‐Sulzbach, Anjana Shenoy, Noa Bossel Ben‐Moshe, Anya Pavlovsky, Rinat Bernstein‐Molho, Eytan Domany, Iris Barshack, Tamar Geiger, Bella Kaufman, Einav Nili Gal‐Yam   +14 more
wiley   +1 more source

Tumor-targeted molecular imaging for monitoring response to therapy in soft tissue sarcomas [PDF]

, 2008
Renata Pasqualini
openalex   +1 more source

Molecular targeted therapy of cancer: The progress and future prospect

, 2017
X. Ke, Lisong Shen
semanticscholar   +1 more source

Tonic signaling of the B‐cell antigen‐specific receptor is a common functional hallmark in chronic lymphocytic leukemia cell phosphoproteomes at early disease stages

Molecular Oncology, EarlyView.
B‐cell chronic lymphocytic leukemia (B‐CLL) and monoclonal B‐cell lymphocytosis (MBL) show altered proteomes and phosphoproteomes, analyzed using mass spectrometry, protein microarrays, and western blotting. Identifying 2970 proteins and 316 phosphoproteins, including 55 novel phosphopeptides, we reveal BCR and NF‐kβ/STAT3 signaling in disease ...
Paula Díez, Pablo Juanes‐Velasco, Marina L. García‐Vaquero, Conrad Droste, Alicia Landeira‐Viñuela, Miguel Alcoceba, Helena Fidalgo‐Gómez, Sara Misiego‐Herrero, Almudena Navarro‐Bailón, Mónica Baile, José M. Bastida, Jose Manuel Sanchez‐Santos, Rafael Góngora, Julia Almeida, Marcos Gonzalez‐Diaz, Alberto Orfao, Javier De Las Rivas, Manuel Fuentes   +17 more
wiley   +1 more source

Recent advances in molecular targeted therapy of lung cancer: Possible application in translation medicine. [PDF]

Iran J Basic Med Sci
Salmani-Javan E, Farhoudi Sefidan Jadid M, Zarghami N.   +2 more
europepmc   +1 more source

Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma progressing after molecular targeted therapy: A multicenter prospective observational study. [PDF]

Medicine (Baltimore), 2022
Sugimoto R, Satoh T, Ueda A, Senju T, Tanaka Y, Yamashita S, Koyanagi T, Kurashige T, Higuchi N, Nakamura T, Tanaka M, Azuma Y, Ohno A, Ooho A, Ooe M, Mutsuki T, Uchimura K, Kuniyoshi M, Tada S, Aratake Y, Yoshimoto T, Yamashita N, Harada S, Nakamuta M, Motomura K, Kohjima M, Liver disease Investigators’ Network of Kyushu University & Surrounding Hospitals (LINKS).   +26 more
europepmc   +1 more source

Potential for molecular-targeted therapy targeting human epidermal growth factor receptor-2 for invasive bladder cancer

, 2007
Yoshiaki Yamada, Katsuya Naruse, Kogenta Nakamura, Shigeyuki Aoki, Tomohiro Taki, Motoi Tobiume, Kenji Zennami, Remi Katsuda, Yasusuke Inoue, Hiroshi Noguchi, Nobuaki Honda   +10 more
openalex   +2 more sources